What helps with chronic kidney disease? Reliable information

Wondering what helps with chronic kidney disease? In this article, we explain which methods are supported by guidelines and research: from blood pressure control and diet to supportive therapies, such as antioxidants and hydrogen inhalation. Find out what can actually support kidney health in 2026.

Chronic kidney disease: What it is and why it requires treatment on multiple levels

If you're wondering, What helps with chronic kidney disease?, it’s best to start by covering the basics. Chronic kidney disease (CKD) is a condition in which the kidneys gradually lose their ability to filter blood and maintain fluid and electrolyte balance. It’s not just about a single creatinine result. The diagnosis is usually based on abnormalities that have persisted for at least 3 months, such as a reduced eGFR, the presence of protein in the urine, changes seen on imaging studies, or other signs of kidney damage.

The Scale of the Problem and Stages of Chronic Kidney Disease

Chronic kidney disease affects approximately 10–15% adults, so it is not a rare diagnosis. In practice, this means that the disease affects roughly 1 in 7–10 people. The prevalence increases with age, but diabetes, hypertension, obesity, cardiovascular disease, and a history of kidney damage also play a significant role.

The severity of CKD is usually assessed based on the eGFR, or estimated glomerular filtration rate. There are generally 5 main stages: from G1, when filtration is still normal or nearly normal, to G5, which represents end-stage renal failure. At the same time, the degree of albuminuria or proteinuria is assessed, as it is the loss of protein in the urine that significantly affects the prognosis. Two people with similar creatinine levels may have completely different risks of disease progression if one has significant proteinuria and the other does not.

This is important because the answer to the question What helps with chronic kidney disease? It depends on the specific situation. The approach differs for a person with early-stage diabetic nephropathy, for polycystic kidney disease, and for a patient on dialysis. However, the common goal is similar: to slow the loss of kidney function, reduce complications, and improve daily functioning.

Why does the disease remain asymptomatic for so long?

One of the biggest problems is that CKD progresses silently for a long time. The kidneys have a large functional reserve, so even a marked decline in filtration may not immediately cause severe symptoms. By the time symptoms such as weakness, itchy skin, swelling, high blood pressure, nocturia, or loss of appetite appear, the disease is often already advanced.

That is exactly why simple checkups are so important: creatinine, eGFR, urinalysis, and assessment of albuminuria. People with diabetes, high blood pressure, or heart disease should have these tests done regularly. In daily practice, many cases are detected not because the patient experienced kidney pain, but because test results showed abnormalities.

Oxidative stress, inflammation, and fibrosis

To understand what actually helps, you need to know how chronic kidney disease (CKD) progresses. In a diseased kidney, several mechanisms overlap. One of them is oxidative stress, that is, an excess of reactive oxygen species that damage proteins, fats, and cellular DNA. The second is chronic inflammation, which perpetuates tissue damage. The third process is fibrosis, which is the replacement of healthy kidney tissue with scar tissue. As this process progresses, the kidney loses its ability to regenerate.

Added to this are damage to the tubule and glomerular cells, microcirculatory disorders, and the activation of hormonal systems that raise blood pressure within the kidneys themselves. This is why the treatment of CKD rarely relies on a single approach. It requires simultaneous management of blood pressure, proteinuria, blood glucose levels, diet, body weight, and factors that exacerbate oxidative stress. The sooner you take action, the greater the chance that you’ll slow the progression for years to come.

What helps the most: treating the underlying cause, controlling blood pressure, and modern nephroprotective medications

If you're asking specifically, What helps with chronic kidney disease? Based on the best evidence from research, the answer is quite clear: treating the underlying cause of the disease, effectively controlling blood pressure, reducing proteinuria, and using appropriately selected nephroprotective medications. These are not merely „generally healthy” measures, but interventions that actually slow the rate of decline in kidney function.

ACEIs and ARBs in the Reduction of Proteinuria

The basis of treatment for many patients is angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs). Their role is not limited to lowering blood pressure. These medications also reduce the pressure inside the renal glomeruli, thereby limiting protein leakage into the urine. And the lower the proteinuria, the lower the risk of further kidney damage.

The KDIGO guidelines consider ACE inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) to be one of the most important pillars of therapy for patients with chronic kidney disease (CKD) and albuminuria. In practice, this means that the doctor does not focus solely on blood pressure readings, but also on whether the amount of protein lost in the urine can be reduced. In some patients, creatinine levels may temporarily rise slightly after starting treatment, so regular monitoring is necessary. This does not mean that the medication is harmful, but rather that the body’s response and potassium levels need to be assessed.

The most common mistake is stopping medication too soon after a single poor test result or taking doses irregularly. Kidney protection is effective only when treatment is continuous and monitored. It is also important to achieve target blood pressure levels, because chronic hypertension affects the kidneys like a constant overload on a filter operating under excessive pressure.

SGLT2 and Modern Kidney Protection

In recent years, the following have taken on great importance: SGLT2 inhibitors. Initially, they were associated mainly with the treatment of type 2 diabetes, but today we know that they also have a protective effect on the kidneys, in part independently of glucose levels themselves. Their mechanism of action includes, among other things, a reduction in excessive glomerular filtration, improved renal hemodynamics, and beneficial effects on the cardiovascular system.

This is particularly important in diabetic kidney disease, where the rate of decline in kidney function can be rapid. Well-managed treatment can slow the decline in eGFR and delay the onset of advanced kidney failure. An additional benefit is a lower risk of hospitalization due to heart failure, which is particularly important because kidney and heart diseases very often occur together.

In practice, this isn’t a „miracle drug,” but rather another piece of the puzzle. If a patient has poorly controlled blood pressure, high salt intake, and consistently high blood sugar, an SGLT2 inhibitor alone won’t solve the problem. But as part of standard therapy, it is one of the most important tools for protecting the kidneys today.

Why Treating the Underlying Condition Is Crucial

Chronic kidney disease rarely develops on its own. It is usually caused by underlying condition: diabetes, hypertension, glomerulonephritis, drug-induced nephropathy, autoimmune diseases, urinary tract abnormalities, or chronic infections. Therefore, the answer to the question of what helps with chronic kidney disease is also: effective treatment of the underlying cause.

If diabetes is the cause, good glycemic control is essential. If high blood pressure is the predominant issue, regular antihypertensive therapy is crucial. When the problem is an active autoimmune disease, immunosuppressive therapy is sometimes necessary. In some patients, additional treatment is required for anemia, calcium-phosphate metabolism disorders, metabolic acidosis, or recurrent edema.

The greatest benefits come from actions that are measurable. It is therefore important to monitor not only the patient’s well-being but also trends in creatinine, eGFR, albuminuria, blood pressure, glycated hemoglobin, and body weight. In CKD, effective treatment is one that improves outcomes over months and years, rather than merely providing a temporary sense of improvement.

A Diet and Lifestyle That Can Take the Strain Off Your Kidneys

Diet and daily habits are no substitute for medication, but they do have a very significant impact on the strain on the kidneys. If you want to know, What helps with chronic kidney disease? Aside from medication, a well-balanced diet, weight management, and minimizing factors that contribute to water retention are among the most practical steps one can take.

Salt, Protein, and Body Weight

The first point is salt restriction. Excess sodium raises blood pressure, increases swelling, and reduces the effectiveness of some nephroprotective medications. In practice, the problem is usually not just adding salt to soup, but mainly processed foods: commercial baked goods, deli meats, processed cheeses, ready-made sauces, fast food, bouillon cubes, and salty snacks. Even if you don’t clearly taste the salt, your total sodium intake throughout the day can still be high.

The second point is moderate protein intake. The kidneys must eliminate the byproducts of protein metabolism, so an excess of protein can increase the metabolic burden. However, this does not mean switching to an extremely low-protein diet on your own. Too little protein can lead to malnutrition and muscle loss, especially in older adults. The most sensible approach is to adjust your protein intake based on the stage of chronic kidney disease (CKD), your body weight, your age, and whether you are pre-dialysis or already on dialysis.

The third element is body weight. Obesity exacerbates insulin resistance, raises blood pressure, promotes inflammation, and worsens the renal prognosis. Even moderate weight loss can improve blood pressure and blood glucose control. This isn’t about aggressive weight-loss diets, but rather a plan that’s sustainable. With CKD, consistency and regularity are more important than rapid weight loss.

How to Reduce Swelling and Daily Strain on the Kidneys

Swelling occurs when the body retains too much sodium and water, or when severe proteinuria disrupts fluid balance. In practice, a few simple rules can help. First, monitor your body weight regularly, preferably at the same time of day. A sudden increase of 1–2 kg over a short period of time may indicate fluid retention. Second, pay attention to tight-fitting socks, swollen ankles, and shortness of breath during physical activity. These are signs that you need prompt medical evaluation.

It is also important to avoid putting daily strain on the kidneys. This includes dehydration, overuse of nonsteroidal anti-inflammatory drugs, unregulated use of supplements, very high-protein diets, and haphazard mixing of herbal preparations. Many people look for a simple „kidney remedy,” but eliminating the factors that systematically damage the kidneys is actually more beneficial.

Physical activity also helps, as long as it is chosen wisely. Regular walking, using a stationary bike, or moderate-intensity exercise improve blood pressure, glucose tolerance, and cardiovascular fitness. If you have advanced chronic kidney disease (CKD), it’s a good idea to discuss your exercise plan with your doctor, especially if you have anemia, shortness of breath, or heart problems.

Supplementation shouldn't be the first choice. It's best to start by laying the groundwork: less salt, the right amount of protein, and monitoring your weight, blood pressure, and blood sugar. Only then can you reasonably assess whether any additional support makes sense.

Antioxidants in Chronic Kidney Disease: What the Research Shows and What the Limitations Are

Oxidative stress is a key factor in the progression of CKD, so the question of antioxidants naturally arises. This is a topic that has generated a great deal of interest but requires an objective approach. Some of the results are promising, but supplements cannot be presented as a simple solution for damaged kidneys.

What Does the Cochrane Review Show?

The most important reference is the Cochrane review covering 95 randomized clinical trials and 10,468 patients. This is a substantial topic, so it’s worth taking it seriously. However, the conclusion isn’t black and white. Antioxidants did not reduce the overall risk of death, which immediately dampens overly high expectations.

On the other hand, the analysis suggested that antioxidants could reduce cardiovascular risk and progression to kidney failure. Some studies also showed improvements in selected renal function parameters, such as a decrease in creatinine or a beneficial effect on other markers. The problem is that the quality of the evidence was rated as moderate or low, and the studies themselves were highly heterogeneous.

This means that not all supplements worked the same way, the doses varied, the duration of treatment also differed, and the patient groups were not homogeneous. In practice, this review does not provide a simple prescription along the lines of: „Take a specific antioxidant for 8 weeks and your kidney function will improve.” Rather, it suggests that the approach makes biological sense, but better and more standardized studies are needed.

Vitamins C and E, coenzyme Q10, and NAC

The most commonly discussed topics in PChN are vitamin C, vitamin E, coenzyme Q10 and N-acetylcysteine (NAC). Each of these supplements has a slightly different mechanism of action. Vitamin C helps neutralize free radicals, vitamin E protects cell membranes from oxidation, coenzyme Q10 supports mitochondrial function, and NAC plays a role in the regeneration of glutathione, one of the body’s main endogenous antioxidants.

It sounds logical, but clinically the situation is more complex. In some patients, improvements in certain markers can be observed, while in others the effect is minimal or nonexistent. Some studies suggest benefits for oxidative stress, while others suggest benefits for cardiovascular parameters; however, there is no basis for considering any of these supplements to be a standard of care equivalent to nephroprotective drugs.

So if you’re considering this type of support, think of it as a supplement that should be evaluated on a case-by-case basis. Especially with chronic kidney disease (CKD), the „more is better” principle doesn’t apply, because the kidneys are responsible for removing many metabolic byproducts, and an excess of certain nutrients can do more harm than good.

When Supplementation Can Be Problematic

The biggest problem concerns high doses and combining multiple medications on one's own. Some studies have reported a higher risk of infection or cardiovascular events among people taking antioxidants. This does not mean that every supplement is dangerous, but rather that the margin of safety may be narrower in cases of advanced chronic kidney disease.

In addition, not every product available on the market has a predictable composition and quality. Patients with CKD should be especially cautious about multi-ingredient preparations, herbal blends, and supplements purchased based on promises of rapid kidney recovery. The problem may lie not only in the active ingredient but also in additives, excess potassium, phosphorus, or other components that are harmful in cases of kidney failure.

The most sensible approach is simple: if you are considering an antioxidant, do so after evaluating test results, the stage of CKD, the list of medications, and the treatment goal. Support is assessed differently for a patient with early albuminuria than for a patient with an eGFR below 30 mL/min/1.73 m² or on dialysis.

Hydrogen inhalation and other forms of H2: promising support, but not a substitute for therapy

In the context of oxidative stress, the topic of molecular hydrogen is coming up more and more often. It is one of the adjunctive therapies that is attracting interest due to its potential antioxidant and anti-inflammatory effects. However, it must be made clear: at present, it is not a substitute for standard treatment of chronic kidney disease, but rather an area of ongoing research.

How Hydrogen Can Work at the Cellular Level

In experimental studies, molecular hydrogen has been linked to the protection of mitochondria, the reduction of oxidative damage to proteins and DNA, and the inhibition of certain inflammatory pathways. In animal models, a reduction in renal fibrosis, a decrease in proteinuria, and improvements in selected renal biomarkers have also been observed. This is important because oxidative stress, inflammation, and fibrosis are the driving forces behind the progression of CKD.

There are several forms of H2 administration. In practice, the following are studied: hydrogen inhalation, hydrogen-enriched water and hydrogen-containing dialysate. In animal models, the concentration range was very wide, from approximately 1% to as high as 67%. In human inhalation studies, the concentrations most commonly analyzed were around 1–2.5% H2 administered over several hours. This shows that laboratory results cannot be mechanically applied to clinical practice.

Study Results in Dialysis Patients

The most interesting data in humans mainly concern dialysis patients. In one of the cited studies, the following was observed in this group after hydrogen administration decrease in CRP, which is a marker of inflammation, and d-ROMs, which reflect the level of oxidative stress. At the same time, an increase in antioxidant potential was observed. This suggests that H2 may influence the body’s biochemical environment in a way that is beneficial for patients suffering from chronic inflammation.

Two case reports were also described in which the combination of hydrogen inhalation with dialysis using hydrogen-enriched dialysate was associated with less fatigue after dialysis. This is a significant finding, because for many patients, post-operative weakness is one of the biggest issues affecting their quality of life. However, we must keep things in perspective: a case report is a valuable clinical observation, but it is not the same as a large randomized trial.

In addition, studies on hydrogen-based dialysis have shown a greater reduction in the percentage of oxidized albumin compared to standard dialysate. From a biological perspective, this is consistent with the hypothesis of reducing oxidative stress. From a clinical perspective, however, we still need to determine whether this effect translates into harder endpoints: slower disease progression, fewer hospitalizations, or improved survival.

Ongoing research and what we don't know yet

This issue is constantly evolving. In Japan, work has begun on A 24-week safety study in patients with CKD G5D, that is, advanced chronic kidney disease requiring dialysis. Among other things, the study is examining the safety of hydrogen inhalation during dialysis, as well as its effects on anemia, fatigue, and vascular function. The very fact that such a study is being conducted is significant, as it demonstrates that this field of research is being taken seriously.

At the same time, it is important to honestly acknowledge the limitations. There is a lack of large, multicenter, long-term studies involving patients at various stages of CKD. There is not yet a single, universally accepted standard regarding session duration, H2 concentration, inhalation frequency, and patient selection criteria. In practice, this means that even if the mechanism seems reasonable and the initial results are promising, one must not promise to halt the disease through inhalation therapy alone.

So the most accurate way to put it is this: hydrogen can be as a supplement to standard therapy, especially when the goal is to provide support in the areas of oxidative stress, inflammation, or subjective fatigue; however, it is not a substitute for nephroprotective medications, blood pressure management, or dialysis.

How to Safely Use Adjuvant Therapies for Chronic Kidney Disease

Complementary therapies only make sense when they are properly integrated into the overall treatment plan. When it comes to chronic kidney disease (CKD), the most harmful approach is to think in terms of „either medication or a natural remedy.” In practice, a safe approach involves using supplements to support the primary treatment rather than competing with it.

What Not to Replace with Adjuvant Therapy

Whether you're talking about antioxidants, H2 inhalation, or other complementary methods, they should not replace ACE inhibitors, ARBs, SGLT2 inhibitors, blood glucose control, blood pressure control or the recommended dialysis treatment. These are the interventions with the strongest scientific evidence, and they determine the rate of disease progression.

If, after starting adjunctive therapy, a patient neglects to monitor their blood pressure, stops taking their medications „because they feel better,” or ignores rising creatinine levels, the result may be the opposite of what was intended. Additional support only makes sense if the basics are consistently followed.

How to Assess the Security of a Device and a Protocol

If you're considering hydrogen inhalation, focus first and foremost on technical safety and consistency of parameters. Some good questions to ask are: Does the device have the appropriate electrical safety certifications? Are the gas parameters verified? Does the manufacturer provide instructions for use, session duration, and maintenance guidelines? In practice, it’s not just the therapy concept itself that matters, but also the quality of the equipment and the predictability of its performance.

It is also advisable to avoid protocols based solely on promises without data on the method of administration. With chronic kidney disease (CKD), the details matter: session duration, frequency, treatment tolerance, potential combination with dialysis therapy, and monitoring of outcomes. If you cannot clearly explain exactly what you are using and why, it is difficult to speak of a reasonable course of action.

Safety also means monitoring after implementation. For each supportive method, it’s a good idea to determine which indicators you’ll be tracking. These may include: how you feel after dialysis, fatigue, blood pressure, body weight, CRP, and, above all, standard nephrology test results. Without such a plan, it’s easy to confuse a momentary impression with a real benefit.

What to Ask a Nephrologist Before Starting Treatment

Before starting adjunctive therapy, it’s a good idea to prepare a specific list of questions. This will ensure that your conversation with the nephrologist is focused and not based on the general question, „Will this help me?”.

1. At your stage of chronic kidney disease, does this method make sense as an adjunct to treatment?
2. What should the goal be: reduced proteinuria, less fatigue, better dialysis tolerance, or an effect on inflammatory markers?
3. Are there any contraindications related to your comorbidities, medications, or test results?
4. What metrics should be monitored after implementation, and how long should we wait to evaluate the results?
5. Does this method interfere with the current treatment plan, including dialysis, diuretics, antihypertensive medications, or antidiabetic medications?

This approach helps organize the topic and prevents disappointment. When it comes to chronic kidney disease, the best results usually come not from a single „breakthrough,” but from a steady, consistent combination of methods with the strongest scientific backing, supplemented by safe interventions with clearly defined goals.

Frequently Asked Questions

In practice, the most effective approach to chronic kidney disease (CKD) is a combination of well-managed causal treatment, control of blood pressure and proteinuria, and daily habits that do not overburden the kidneys. Adjunctive therapies, including antioxidants and hydrogen inhalation, should be considered judiciously and always in light of test results and the treatment plan established with a nephrologist.

Learn more - Click here: https://anev.com.pl/